OncoCyte Corporation (OCX) Technical Exchange News June 18, 2025, 00:32 UTC 1 NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Oncocyte Corporation - Common Stock. Comment Full text
Protagenic Therapeutics Inc. (PTIXW) Technical Exchange News June 17, 2025, 19:23 UTC 6 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Protagenic Therapeutics Inc. (PTIX) Technical Exchange News June 17, 2025, 19:23 UTC 4 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Clene Inc. (CLNNW) Technical Exchange News June 17, 2025, 19:22 UTC 6 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Clene Inc. (CLNN) Technical Exchange News June 17, 2025, 19:22 UTC 6 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
AIM ImmunoTech Inc. (AIM) Technical Exchange News June 17, 2025, 07:13 UTC 7 NYSE MKT symbol attribute type Security_Name was changed. Previous value: -. New value: AIM ImmunoTech Inc. Common Stock. Comment Full text
AIM ImmunoTech Inc. (AIM) Technical Exchange News June 17, 2025, 07:13 UTC 8 NYSE MKT symbol attribute type Test_mode was changed. Previous value: -. New value: N. Comment Full text
Lyell Immunopharma (LYEL) Technical Exchange News June 17, 2025, 01:59 UTC 5 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Lyell Immunopharma (LYEL) Technical Exchange News June 16, 2025, 18:36 UTC 2 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
GlycoMimetics Inc. (GLYC) Technical Exchange News June 16, 2025, 07:40 UTC 3 GlycoMimetics Inc. (GLYC) was removed from the list of traded instruments on NASDAQ exchange Comment Full text